Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
1 Roche has indicated that the Phase III clinical program for CT-388 in obesity, Enith1 and Enith2, is expected to begin in the first quarter of 2026
Bee products and colorectal Canceractive components and mechanism of action
Our nearest branch is wherever you are
Enquire Now Frequently Asked Questions Insulin-like Growth Factors Market Size is valued at USD 275.1 Mn in 2023 and is predicted to reach USD 406.1 Mn by the year 2031 Insulin-like Growth Factors Market is predicted to develop at an 5.13% CAGR during the forecast period for 2024-2031
Most participants kept the weight off
US$ 27.23
US$ 28.33
US$ 29.82
